Immunitybio (IBRX) traded down -1.08 % during a 24 hours period ending at 11:02 PM Central Europe on Monday 26th. One Immunitybio stock can currently be bought for about USD 7.81 on popular exchanges. Current supply of Immunitybio stocks is 1.1 bn. Immunitybio has a current market capitalization of USD 8.7 bn and approximately USD 48.7 mn worth of Immunitybio was traded on exchanges in the last 24 hours. Since last month end, Immunitybio has traded -4.86 % down. Simple moving average of last 200 days is at USD 7.76. The highest price of past 52 weeks was recorded at USD 12.43 on 02/25/2026. 52 weeks low was at USD 1.95 on 12/31/2025.

Here is how related stocks have performed in the past 24 hours:

  • Ryder System (R) traded up 2.02 % and now trades at USD 282.11. Ryder System has a market capitalisation of USD 10.4 bn. Ryder System has a current price to earnings ratio of 20.52.

  • Wintrust (WTFC) traded up 0.68 % and now trades at USD 151.17. Current market capitalisation for Wintrust is USD 10.2 bn. Current price/earnings ratio for Wintrust is 11.53.

  • Domino’s Pizza (DPZ) traded down -1.29 % and now trades at USD 313.32. Domino’s Pizza has a market capitalisation of USD 10.3 bn. Domino’s Pizza has a current price to earnings ratio of 17.22.

  • Southstate Bank (SSB) traded up 0.28 % and now trades at USD 105.4. Current market capitalisation for Southstate Bank is USD 10.2 bn. Current price/earnings ratio for Southstate Bank is 11.22.

  • Insulet (PODD) traded up 0.6 % and now trades at USD 149.26. Current market capitalisation for Insulet is USD 10.3 bn. Insulet has a current price to earnings ratio of 28.21.

About Immunitybio

ImmunityBio, Inc. is a biotechnology company that specializes in developing cell and immunotherapy products for treating various diseases, including cancers, infectious, and inflammatory diseases. This company operates in the Health Care sector and has its main base in Culver City, United States. Their mission is to revolutionize the way these diseases are treated by focusing on innovative cell and immunotherapy techniques.